Companies: 10,795·Total market cap: $144.5T
AREV Life Sciences Global Corp.

AREV Life Sciences Global Corp.

AREVFOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$15881
P/E Ratio
52W High$0.01
52W Low$0.0005
Overview

AREV Life Sciences Global Corp. (AREVF) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

AREVF · earnings · updated Jun 9, 2026

No earnings history available.

Next Earnings Date

Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.
No earnings history available.
No analyst estimates available for AREVF.

About Earnings & Data Methodology

Data source: Financial Modeling Prep (FMP)  |  Updated: Hourly  |  Surprise%: (Actual − Estimate) / |Estimate| × 100  |  Fiscal year: AREVF ends December

AREV Life Sciences Global Corp. (AREVF) reports earnings quarterly as a OTC-listed Drug Manufacturers - Specialty & Generic company. The next AREVF earnings date is expected around September 1, 2026.

Each quarter, investors track AREVF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. AREVF revenue tab →

Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
AREVF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Frequently asked questions

AREVF earnings · 3 questions

AREV Life Sciences Global Corp.'s next earnings report is expected around September 1, 2026. AREVF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; AREVF historically reports after market close (AMC).

AREVF earnings datewhen is AREVF earningsAREVF next earnings datewhen does AREVF report earningsAREVF earnings calendar

Source: FMP · AREV Life Sciences Global Corp. SEC filings · US GAAP · AREV Life Sciences Global Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026